Report cover image

Global Next-Generation Sequencing on Drug Development Market

Publisher BCC Research
Published Aug 29, 2023
Length 177 Pages
SKU # WA18157040

Description

Global Next-Generation Sequencing on Drug Development Market



Report Scope:

The scope of this report includes NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS in drug development are given for 2020, 2021, 2022, 2023 and 2028.

This report reviews the NGS technologies and explains why NGS is important in drug development. It then discusses some of the significant research initiatives that impact NGS. The main market-driving forces are also discussed.

This report examines the markets by product type, end user and region. This report provides market data and forecasts for NGS by product type, including instruments, consumables and services for drug development.

Specific geographic markets are discussed, including North America, Europe, Asia-Pacific and the Rest of the World.

BCC Research summarizes the main industry acquisitions and strategic alliances from Jan. 2020, through Dec. 2022, including key alliance trends.

Report Includes:

52 data tables and 39 additional tables

An overview of the global markets for next-generation sequencing on drug development

Estimation of market size and analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028

Highlights of the market potential and characterization of next-generation sequencing on drug development market by product, service, end-user type, and region

Examination of the key drivers and constraints that will shape the market for next-generation sequencing on drug development and discussion on the upcoming market opportunities and areas of focus to forecast the market into various segments and subsegments

Coverage of recent advances, emerging technologies, and developments of the industry

Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry

Profiles of the key companies of the industry, including 10x Genomics, Bio-Rad Laboratories Inc., Oxford Nanopore Technologies, Qiagen and Takara Bio Inc.

Companies Mentioned

10X GENOMICS
AGILENT TECHNOLOGIES INC.
BGI (Beijing Genomics Institute)
BIO-RAD LABORATORIES INC.
CD GENOMICS
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
Micronoma
NEW ENGLAND BIOLABS
OXFORD NANOPORE TECHNOLOGIES
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PERKINELMER INC.
PRECISION FOR MEDICINE, FORMERLY APOCELL
PROMEGA CORP.
Psomagen Inc.
QIAGEN
ROCHE HOLDING AG
TAKARA BIO INC.
TECAN GROUP LTD.
THERMO FISHER SCIENTIFIC INC.

Table of Contents

177 Pages
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Research Methodology
Information Sources
Geographic Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market Overview
Introduction
Technology Background
Structure and Importance of DNA
DNA Sequencing Technologies
Whole Genome Sequencing
Targeted Resequencing
ChIP Sequencing
RNA Sequencing
Methylation Sequencing
History of DNA Sequencing
Sanger Sequencing
Introduction to Next Generation Sequencing (NGS)
Advantages of NGS
Roche 454 Pyrosequencing
Illumina NGS
Thermo Fisher Scientific (Life Technologies) NGS
Sequencing Instruments
Benchtop Sequencers
Informatics Technologies
NGS in Drug Development
NGS Service Providers
Chapter 4 Market Dynamics
Market Drivers
Increasing R&D Activities using NGS technologies
Increase in Healthcare Expenditure
Technological Advancements in Sequencing Platforms
Shift Towards Precision Medicine
Growing demand of NGS for Designing Individualized Medicine to Cancer Patients
High Accuracy and Low Cost
Market Restraints
Limitations Associated with NGS Technology
Other Clinical Sequencing Technology Challenges
Market Opportunities
Rising R&D in NGS creates lucrative Opportunities for Manufacturers
Chapter 5 NGS in Drug Development by Product Type
Introduction
Instruments
Consumables
Services
Chapter 6 NGS Market in Drug Development by End User
Pharmaceutical and Biotechnology Companies
Academic and Research Centers
Other End Users
Chapter 7 NGS Market in Drug Development by Region
Market Overview and Discussion
North America
Asia-Pacific
Europe
Rest of the World
Chapter 8 Sustainability of NGS in Drug Development: An ESG Perspective
Introduction to ESG
Sustainability of NGS in Drug Development: An ESG Perspective
Key ESG Issues
Consumer Attitudes Towards ESG
Industry ESG Performance Analysis
Case Study
Environment
Social
Governance
Concluding Remarks from BCC
Chapter 9 Emerging Technologies and Developments
Overview
Emerging Technologies in the Market
Application of Artificial Intelligence (AI) in NGS
Single-Molecule Real-Time Sequencing
Nanopore Technology
Microscopy-Based Sequencing
Chapter 10 Patent Analysis
Introduction
Patents on NGS by Region
Chapter 11 M&A and Funding Outlook
M&A Analysis
Chapter 12 Competitive Landscape
Global Company Ranking
Global Company Ranking for NGS Instruments in Drug Development
Global Company Ranking for NGS Consumables in Drug Development
Global Company Ranking for NGS Services in Drug Development
Chapter 13 Company Profiles
10X GENOMICS
AGILENT TECHNOLOGIES INC.
BGI (BEIJING GENOMICS INSTITUTE)
BIO-RAD LABORATORIES INC.
CD GENOMICS
ILLUMINA INC.
INTEGRATED DNA TECHNOLOGIES INC.
MICRONOMA
NEW ENGLAND BIOLABS
OXFORD NANOPORE TECHNOLOGIES
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PERKINELMER INC.
PROMEGA CORP.
PSOMAGEN INC.
PRECISION FOR MEDICINE, FORMERLY APOCELL
QIAGEN
ROCHE HOLDING AG
THERMO FISHER SCIENTIFIC INC.
TAKARA BIO INC.
TECAN GROUP LTD.
Chapter 14 Appendix: Acronyms

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us